# Osseolink USA, LLC – FDA Inspection, Jan 29, 2014

Source: https://www.keypedia.com/records/fda_inspections/osseolink-usa-llc/c25f25be-fc5b-41db-9086-a8c82d1e0583
Source feed: FDA_Inspections

> FDA inspection 863826 of Osseolink USA, LLC, January 29, 2014. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 863826
- Company Name: Osseolink USA, LLC
- Inspection Date: 2014-01-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1145622 - 2021-06-10
- [FDA Inspection 1099236 - 2019-06-18](https://www.keypedia.com/records/fda_inspections/osseolink-usa-llc/0f9c391b-d8a8-42b1-aed7-31c1fe7fa94d)
- [FDA Inspection 884639 - 2014-06-25](https://www.keypedia.com/records/fda_inspections/osseolink-usa-llc/afbdc3ac-8491-4baa-8fa7-65c515c16341)
- FDA Inspection 764359 - 2012-01-19
- [FDA Inspection 640016 - 2010-01-08](https://www.keypedia.com/records/fda_inspections/osseolink-usa-llc/b5a8b790-262c-4255-a07e-bb5879bb26e3)

Company: https://www.keypedia.com/companies/osseolink-usa-llc/7cc0c014-3768-40d8-be9a-057e07025c29

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d